Print Page

Medicine recalls

 
Taiwan: Recall of 艾筆腎上腺素注射筆 0.3 毫克/次 Epipen Epinephrine Auto-Injector
 
In Hong Kong, the above product is not a registered pharmaceutical product. The drug regulatory authorities in Australia, the United States and Canada has issued related news, and the information was posted on the Drug Office website of the Department on Health (DH) on 20 March, 1 April and 3 April 2017 respectively. According to the records of the DH, Luen Cheong Hong Ltd (LCH) has previously imported Epipen 0.15mg and Epipen 0.3mg manufactured by Meridan Medical Technologies, Inc., the US for the treatment of particular patients. As confirmed with LCH, the affected batch of product in the Taiwan announcement has never been imported into Hong Kong. DH will monitor the development of the incident and will continue to liaise with the importers of Epipen products for timely follow-up action.

Please refer to the following Chinese website for details: http://www.drugoffice.gov.hk/eps/news/../27952.html

Ends/Thursday, April 13, 2017
Issued at HKT 16:00
 
Related Information:
Canada: Pfizer Canada recalls two lots of EpiPen / EpiPen Jr auto-injectors (0.3... Posted 2017-04-03
The United States: FDA alerts consumers of nationwide voluntary recall of EpiPen... Posted 2017-04-01
Australia: EpiPen 300 microgram adrenaline injection syringe auto-injector: Reca... Posted 2017-03-20
 
back